NASHUA, N.H., Feb. 8 /PRNewswire-FirstCall/ -- iCAD, Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that management of iCAD, Inc., will discuss the Company's results for the fourth quarter and fiscal year ended December 31, 2006, during a conference call scheduled for Tuesday, March 6, 2007 at 10:00 am ET. The Company's financial results for the fourth quarter and year end are scheduled to be released earlier that day.
Shareholders and other interested parties may participate in the conference call by dialing +1 888-396-2384 (domestic) or +1 617-847-8711 (international) and entering passcode 49851762 a few minutes before 10:00am ET on March 6, 2007. The call will also be broadcast live on the Internet at www.streetevents.com, www.fulldisclosure.com or www.icadmed.com.
A replay of the conference call will be accessible 2 hours after its completion through March 13, 2007 by dialing +1 888-286-8010 (domestic) or +1 617-801-6888 (international) and entering passcode 30830180. The call will also be archived for 90 days at www.streetevents.com, www.fulldisclosure.com and www.icadmed.com.
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer- Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks, Executive VP and CFO at 603-882-5200 or via email at ddeptula@icadmed.com For iCAD Investor Relations, contact Kevin McGrath of Cameron Associates at 212-245-4577 or via email at kevin@cameronassoc.com For iCAD Public Relations, contact Michele Fox of Schwartz Communications at 781-684-0770 or via e-mail at icad@schwartz-pr.com
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:
Certain statements contained in this News Release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.
iCAD, Inc.CONTACT: Darlene Deptula-Hicks, Executive VP and CFO, of iCAD Inc.,+1-603-882-5200, or ddeptula@icadmed.com; Kevin McGrath of CameronAssociates, +1-212-245-4577, or kevin@cameronassoc.com, for iCAD InvestorRelations; or Michele Fox of Schwartz Communications, +1-781-684-0770, oricad@schwartz-pr.com, for iCAD Public Relations
